A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Prednisone (Primary)
- Indications Polymyalgia rheumatica
- Focus Registrational; Therapeutic Use
- Sponsors Mundipharma Research
- 08 Feb 2019 This trial has been discontinued in United Kingdom, according to European Clinical Trials Database.
- 01 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Feb 2014 Status changed from recruiting to active, no longer recruiting reported by ClinicalTrials.gov record.